Intravitreal Injections

What Are Intravitreal Injections?

Intravitreal injections are commonly used to treat retinal diseases like diabetic retinopathy, macular degeneration, macular edema, and retinal vein occlusion. These diseases may cause loss of vision and should be treated as early as possible. Medications such as Lucentis, Avastin, Macugen, or triamcinolone can be injected directly into the eye to help patients maintain their vision, keep vision loss to a minimum, and in some cases, improve vision.

Can Intravitreal Injections Treat Macular Degeneration?

Intravitreal injections are especially effective in treating wet age-related macular degeneration, which accounts for more than 90% of blindness caused by the disease.

What Should I Expect During My Intravitreal Injection Consultation?

Intravitreal injection is performed in our office and requires only a local anesthetic. First, the eye is numbed with anesthetic eye drops to help minimize discomfort. Next, the eye is cleaned with an antiseptic solution. The medication is then injected directly into the eye.

Will I Need Anesthesia For Intravitreal Injections?

Intravitreal injection is performed in our office and requires only a local anesthetic.

How Often Do I Need Intravitreal Injections?

Depending on the condition being treated, intravitreal injections may be administered as frequently as once a month.

Schedule a Consultation

If you are interested in learning more about intravitreal injections, please call us today to schedule an appointment. An Illinois Retina Associates specialist will discuss all treatment options with you, including the latest medications to treat your condition.

Contact Us Today to learn more or to schedule an appointment


Patient safety is our top priority. If you are having flu-like symptoms, fever, cough, chills, shortness of breath please DO NOT VISIT US at this time and contact your local health provider.

To ensure your health is protected, we are limiting the number of people in our offices. We are asking that ONLY PATIENTS enter our office. Visitors and/or support persons should remain in the car or other location. If the visitor or support person must be present, screening questions will be asked and if positive responses are received the visitor/ support person will not be allowed in the office.

We appreciate your cooperation and understanding.

For ongoing updates and recommendations, please visit the following websites: Centers For Disease Control (, American Academy of Ophthalmology (, World Health Organization (